跳至主要内容
临床试验/NCT06029465
NCT06029465尚未招募不适用

Analyzing Engagement Trends in Rhabdomyosarcoma Clinical Trials: A Study of Participation Patterns Among Those Affected by the Disorder

Power Life Sciences Inc.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2024年10月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
Rate of rhabdomyosarcoma patients who remain in clinical trial to trial completion

研究概览

简要总结

The study seeks to delve into the firsthand experiences of patients diagnosed with rhabdomyosarcoma who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals.

The data collected from this study will help improve future outcomes for all rhabdomyosarcoma patients as well as those in under-represented demographic groups.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of rhabdomyosarcoma
  • Considered reliable, able to understand, and willing to perform all study procedures
  • Signed Written Informed Consent

排除标准

  • Currently enrolled in, have completed or have discontinued from a clinical trial involving an investigational drug
  • Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
  • Any serious and/or unstable pre-existing medical disorders

结局指标

主要结局

Rate of rhabdomyosarcoma patients who remain in clinical trial to trial completion

时间窗: 12 months

Number of rhabdomyosarcoma patients who decide to enroll in a clinical trial

时间窗: 3 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验